A Mouse Brain-based Multi-omics Integrative Approach Reveals Potential Blood Biomarkers for Ischemic Stroke.


Journal

Molecular & cellular proteomics : MCP
ISSN: 1535-9484
Titre abrégé: Mol Cell Proteomics
Pays: United States
ID NLM: 101125647

Informations de publication

Date de publication:
12 2020
Historique:
received: 10 08 2020
pubmed: 2 9 2020
medline: 12 8 2021
entrez: 2 9 2020
Statut: ppublish

Résumé

Stroke remains a leading cause of death and disability worldwide. Despite continuous advances, the identification of key molecular signatures in the hyper-acute phase of ischemic stroke is still a primary interest for translational research on stroke diagnosis, prognosis, and treatment. Data integration from high-throughput -

Identifiants

pubmed: 32868372
pii: S1535-9476(20)60003-2
doi: 10.1074/mcp.RA120.002283
pmc: PMC7710142
pii:
doi:

Substances chimiques

Biomarkers 0
Catenins 0
GADD45G protein, human 0
Intracellular Signaling Peptides and Proteins 0
Proteome 0
Delta Catenin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1921-1936

Informations de copyright

© 2020 Simats et al.

Déclaration de conflit d'intérêts

Conflict of interest—The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Brain Res Mol Brain Res. 2004 Feb 5;121(1-2):1-11
pubmed: 14969731
Stroke. 2017 Dec;48(12):e343-e361
pubmed: 29097489
Dtsch Arztebl Int. 2015 Dec 4;112(49):830-6
pubmed: 26754120
Biostatistics. 2003 Apr;4(2):249-64
pubmed: 12925520
Learn Mem. 2012 Jul 16;19(8):319-24
pubmed: 22802593
J Cereb Blood Flow Metab. 1998 Jun;18(6):646-57
pubmed: 9626189
Cancer Ther. 2009;7(A):268-276
pubmed: 19652693
Ann Clin Transl Neurol. 2019 Sep;6(9):1681-1695
pubmed: 31400065
Adv Genet. 2016;93:147-90
pubmed: 26915271
J Biol Chem. 2010 Jul 2;285(27):20675-82
pubmed: 20424167
Bioinformatics. 2009 Nov 1;25(21):2855-6
pubmed: 19706745
Oncogene. 2015 Mar 19;34(12):1542-52
pubmed: 24727894
J Cereb Blood Flow Metab. 2001 Dec;21(12):1430-5
pubmed: 11740204
Neural Regen Res. 2014 Apr 1;9(7):757-8
pubmed: 25206884
Endocrinology. 2010 Oct;151(10):4654-64
pubmed: 20739400
BMC Genomics. 2006 Jun 08;7:142
pubmed: 16762068
Mol Cell Proteomics. 2014 Mar;13(3):907-17
pubmed: 24443746
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
J Intern Med. 2018 May;283(5):461-475
pubmed: 29415332
Bioinformatics. 2005 Jun 1;21(11):2789-90
pubmed: 15797915
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
Neurol Res. 1997 Dec;19(6):641-8
pubmed: 9427967
Bioinformatics. 2009 Feb 1;25(3):415-6
pubmed: 19106121
PLoS One. 2012;7(9):e44207
pubmed: 22970179
Neuron. 2009 Nov 12;64(3):320-7
pubmed: 19914181
Oncotarget. 2015 Sep 29;6(29):27953-65
pubmed: 26172295
J Cereb Blood Flow Metab. 1996 Jan;16(1):1-6
pubmed: 8530541
Proteomics. 2016 Oct;16(19):2533-2544
pubmed: 27343053
Nat Rev Genet. 2012 Mar 13;13(4):227-32
pubmed: 22411467
Stem Cell Reports. 2014 Jun 19;3(1):34-43
pubmed: 25068120
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
J Emerg Med. 2011 Sep;41(3):333-9
pubmed: 20417054
BMC Bioinformatics. 2014 May 29;15:162
pubmed: 24884486
Am J Nephrol. 2009;30(2):135-9
pubmed: 19293565
Int J Stroke. 2012 Jul;7(5):378-85
pubmed: 22712739
J Neurosci. 2011 Mar 30;31(13):4978-90
pubmed: 21451036
J Neurosci Res. 2010 Aug 15;88(11):2350-63
pubmed: 20623542
Mol Cell Proteomics. 2019 Aug 9;18(8 suppl 1):S153-S168
pubmed: 31243065
Prostate. 2009 Mar 1;69(4):411-8
pubmed: 19116988
Inflamm Res. 2012 Nov;61(11):1195-202
pubmed: 22752116
Adv Exp Med Biol. 2013;793:1-19
pubmed: 24104470
Biomark Med. 2013 Feb;7(1):37-47
pubmed: 23387483
Exp Cell Res. 2019 Jan 1;374(1):94-103
pubmed: 30458179
Am Fam Physician. 2015 Apr 15;91(8):528-36
pubmed: 25884860
Stat Appl Genet Mol Biol. 2004;3:Article3
pubmed: 16646809
J Biol Chem. 2008 Nov 21;283(47):32781-91
pubmed: 18809680
J Neuroimmunol. 2014 Sep 15;274(1-2):215-24
pubmed: 25091431
Stroke. 2015 Mar;46(3):915-20
pubmed: 25657186
Stroke. 2009 Jul;40(7):2438-41
pubmed: 19478213
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
Neuroscience. 2002;115(4):1009-21
pubmed: 12453475
J Neurosci Res. 2016 May;94(5):378-88
pubmed: 26900013
Cardiovasc Res. 2015 Nov 1;108(2):254-67
pubmed: 26370247
Stroke. 2015 Dec;46(12):3437-42
pubmed: 26508752

Auteurs

Alba Simats (A)

Neurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Laura Ramiro (L)

Neurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Teresa García-Berrocoso (T)

Neurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Ferran Briansó (F)

Bioinformatics and Biostatistics Unit, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain; Genetics, Microbiology and Statistics Dept., Universitat de Barcelona, Barcelona, Spain.

Ricardo Gonzalo (R)

Bioinformatics and Biostatistics Unit, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Luna Martín (L)

Proteomics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.

Anna Sabé (A)

Proteomics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.

Natalia Gill (N)

Neurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Anna Penalba (A)

Neurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Nuria Colomé (N)

Proteomics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.

Alex Sánchez (A)

Bioinformatics and Biostatistics Unit, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain; Genetics, Microbiology and Statistics Dept., Universitat de Barcelona, Barcelona, Spain.

Francesc Canals (F)

Proteomics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.

Alejandro Bustamante (A)

Neurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Anna Rosell (A)

Neurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Joan Montaner (J)

Neurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: joan.montaner@vhir.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH